Viranto Shot oral solution is a food for special medical purposes containing herbal extracts, vitamins, and minerals intended for the dietary management of individuals with the common cold, flu, sore throat, cough, and respiratory complaints. The product is intended for persons over 18 years of age.
The common cold and flu are viral respiratory infections most commonly manifested by symptoms affecting the upper respiratory tract. As described in a clinical review published in The Lancet Infectious Diseases (https://www.thelancet.com/journals/laninf/home), early symptoms of these infections include impaired respiratory mucosal function, irritation, and initial activation of the immune response, which precede the full development of the disease. These symptoms represent the characteristic early phase of infection in adults.
Medical reviews of upper respiratory tract infections, including the clinical overview published by the National Library of Medicine (NCBI https://www.nlm.nih.gov/), indicate that during the early phase of symptoms, the use of products intended to support the body is often considered, particularly in the context of alleviating subjective symptoms such as throat irritation and cough.
Viranto Shot is formulated to be taken easily as a ready-to-drink solution without preparation, enabling use immediately upon the appearance of the first symptoms, in line with the clinically described course of the common cold and flu in adults.
Source (expert review of common cold and flu symptoms):
Eccles R. Understanding the symptoms of the common cold and influenza.
The Lancet Infectious Diseases, vol. 5 (11), 2005, pages 718–725.
This review explains the pathophysiology and typical symptoms of the common cold and viral upper respiratory tract infections, including cough, sore throat, sneezing, and mucosal inflammation.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7185637/
Source (expert medical overview of URTI – upper respiratory tract infection):
Upper respiratory tract infections (URTIs) – overview and clinical features.
National Center for Biotechnology Information (NCBI), U.S. National Library of Medicine.
This source provides medical context for URTIs, describing the most common symptoms, the dynamics of development, and the typical course in adult patients.
https://www.ncbi.nlm.nih.gov/books/NBK532961/
Viranto Shot contains a combination of carefully selected plant-based ingredients, vitamins and minerals, including Pelargonium root extract (Pelargonium sidoides), elderberry fruit extract (Sambucus nigra), white willow bark extract (Salix alba) and ginger rhizome extract (Zingiber officinale), as well as zinc, copper and vitamin D. These ingredients have traditionally been used in the context of respiratory complaints and symptoms of the common cold and flu.
The use of herbal extracts in upper respiratory tract infections has been described in contemporary scientific research and clinical studies.
In addition, a meta-analysis of controlled studies published in the journal Complementary Therapies in Medicine (https://www.sciencedirect.com/journal/complementary-therapies-in-medicine) examines supplementation with elderberry extract (Sambucus nigra) and its relationship with upper respiratory tract symptoms, including cough and throat discomfort. In the same clinical context, white willow and ginger extracts have been studied in relation to inflammatory processes and the general feeling of discomfort that may occur during viral illnesses.
In addition to herbal extracts, vitamin D, together with zinc and copper, belongs to the group of micronutrients whose role in the normal function of the immune system is defined by European Union regulatory and scientific guidelines. According to officially approved health claims of the European Commission, vitamin D contributes to the normal function of the immune system, which represents the regulatory basis for its use in nutritional products.
Source (regulatory health claim – vitamin D and the immune system): European Union – EUR-Lex (Commission Regulation (EU) No 432/2012). The regulation states that vitamin D contributes to the normal function of the immune system. This serves as the regulatory foundation for the part of the text referring to the role of vitamin D in the normal function of the immune system.
https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX%3A02012R0432-20170822
Viranto Shot is intended for use immediately upon the appearance of the first symptoms of the common cold and flu, at a stage when initial signs such as throat irritation, cough, and a general feeling of fatigue most commonly occur. As described in a clinical review published in The Lancet (https://www.thelancet.com/journals/laninf/home), the early course of the common cold is characterized by the gradual development of symptoms during the first days after infection, when the viral infection is still developing and when, in practice, additional support for the body is often considered.
Medical sources state that in the early phase of respiratory infections, symptoms initially manifest at the level of the upper respiratory tract, with complaints such as throat irritation, cough, and a runny nose. According to information published by the Centers for Disease Control and Prevention (CDC https://www.cdc.gov/index.html), recognizing these early symptoms represents an important part of the clinical understanding of the initial phase of the common cold in adults.
The shot form allows for simple and rapid use, without the need for preparation, dilution, or additional steps, which is in line with practical needs in situations where it is important to act without delay, both at home and outside the home.
Due to its practical packaging and method of use, Viranto Shot is suitable for use at the moment when the first symptoms are recognized and when fast and simple intake of the product is required.
Source (clinical review of the course of the common cold and early symptom phase): Heikkinen T, Järvinen A. The common cold. The Lancet. 2003 Jan 4;361(9351):51–59. doi:10.1016/S0140-6736(03)12162-9. This review article describes the course and phases of the common cold and provides a clinical framework for understanding the early symptomatic phase; in practice, symptoms typically appear and develop during the first days after infection.
https://pubmed.ncbi.nlm.nih.gov/12517470/
Source (medical overview – onset of respiratory infection symptoms): Centers for Disease Control and Prevention (CDC). Common Cold – About Common Cold (Signs & Symptoms). The CDC provides reliable medical information on typical early symptoms of the common cold and explains their gradual development during the first days of infection, which is clinically relevant for recognizing the initial phase of respiratory infections.
https://www.cdc.gov/common-cold/about/index.html
Viranto Shot is packaged in a box containing 10 individual bottles with an oral solution. Each individual bottle represents a single-dose shot form, allowing the product to be carried and used without preparation when it is necessary to react immediately upon the appearance of the first symptoms of the common cold and flu.
Due to a formulation that does not require dosing with a spoon or dilution, Viranto Shot is a good choice as part of a home medicine kit, as well as a product that is practical to keep in a bag, at work, or while traveling, when there are no conditions for using other pharmaceutical forms.
The product should be used in accordance with the instructions and on the recommendation of a physician or pharmacist.
The taste of Viranto Shot is based on a combination of ginger, honey, and lemon, ingredients that are traditionally present in beverages intended for use during the common cold and flu. This combination provides a natural and well-balanced flavor.
A mild taste is particularly important in situations when the product is used in the early phase of symptoms, when the throat mucosa and sense of taste are often more sensitive. Thanks to its liquid shot form and carefully selected flavor profile, Viranto Shot is easy to drink in a single sip.
Pelargonium (Pelargonium sidoides) – use in symptoms of upper respiratory tract infections
Pelargonium root extract (Pelargonium sidoides) is used in acute upper respiratory tract infections, including symptoms such as cough, sore throat, and inflammation of the respiratory mucosa. Its use is based on long-standing application in phytotherapy, as well as on contemporary clinical research examining its role during acute respiratory infections.
White willow (Salix alba) – traditional use for pain and elevated body temperature
White willow bark extract (Salix alba) has traditionally been used in phytotherapy due to the presence of natural salicylates and other bioactive compounds. These substances have been the subject of numerous scientific investigations because of their role in processes associated with inflammation, pain, and elevated body temperature.
Contemporary scientific reviews indicate that white willow bark extracts contain salicin and related components that undergo metabolic processes in the body associated with anti-inflammatory and analgesic mechanisms of action. For this reason, Salix alba is traditionally listed among herbal ingredients used to support the body in conditions accompanied by inflammatory reactions.
Regulatory and professional documents of the European Medicines Agency (EMA https://www.ema.europa.eu/en/homepage) confirm the long-standing use of white willow bark and describe its composition, method of use, and safety profile. These sources document the traditional use of white willow bark for complaints associated with pain, fever, and inflammation, with clearly defined limitations and usage guidelines.
Thanks to these characteristics, white willow bark extract is used as part of formulations that include herbal ingredients with a long history of use and scientifically described bioactive properties.
Source (scientific review – bioactive components and inflammatory processes): Shara M, Stohs SJ. Efficacy and Safety of White Willow Bark (Salix alba) Extracts. Phytotherapy Research. 2015;29(8):1112–1116. This review analyzes the composition of white willow bark extract (Salix alba), focuses on salicylates and other bioactive components, describes their anti-inflammatory and analgesic mechanisms, and provides insight into available clinical data on the efficacy and safety of the extract.
https://pubmed.ncbi.nlm.nih.gov/25997859/
Source (professional review – traditional and contemporary use): European Medicines Agency (EMA) – Committee on Herbal Medicinal Products (HMPC). Assessment report on Salix alba L., cortex (white willow bark). This regulatory and professional document examines the traditional and contemporary medical use of white willow bark (Salix alba), its active components (e.g., salicin), and available data on safety and guidance for phytotherapeutic preparations, including indications for pain, fever, and inflammation.
https://www.ema.europa.eu/en/medicines/herbal/salicis-cortex
Elderberry (Sambucus nigra) – herbal extract used for seasonal respiratory infections
Elderberry fruit extract (Sambucus nigra) has traditionally been used during periods of seasonal upper respiratory tract infections, particularly in autumn and winter. The traditional use of elderberry is documented in regulatory and professional reports of the European Medicines Agency (EMA https://www.ema.europa.eu/en/homepage), which describe its composition, method of use, and safety profile within phytotherapy, based on its long-standing use in Europe.
Contemporary scientific research includes controlled clinical trials and meta-analyses examining supplementation with elderberry extract in upper respiratory tract symptoms. According to a meta-analysis of randomized, controlled clinical trials published in the journal Complementary Therapies in Medicine (https://www.sciencedirect.com/journal/complementary-therapies-in-medicine), these studies analyzed the duration and severity of symptoms such as nasal congestion, cough, throat irritation, and general weakness during seasonal respiratory infections.
Elderberry fruit contains bioactive components, including flavonoids and anthocyanins, which have been the subject of scientific reviews due to their biological properties. According to review articles published in the Journal of International Medical Research (https://journals.sagepub.com/home/imr), these components have been investigated in relation to their activity in respiratory viral infections, providing the basis for their inclusion in modern herbal formulations.
Due to the combination of traditional use and contemporary scientific data, elderberry extract is often included in products intended for adults during periods of seasonal respiratory infections, most commonly as part of combined formulations with other herbal extracts, vitamins, and minerals.
Source (meta-analysis of clinical studies – Sambucus nigra): Hawkins J, et al. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials. Complementary Therapies in Medicine. 2019;42:361–365. This meta-analysis includes controlled clinical trials and evaluates the effect of elderberry extract supplementation on upper respiratory tract symptoms (duration and severity of symptoms).
https://pubmed.ncbi.nlm.nih.gov/30670267/
Source (review of traditional and contemporary use – regulatory context): European Medicines Agency (EMA) – Committee on Herbal Medicinal Products (HMPC). Assessment report on Sambucus nigra L., fructus. This regulatory and professional document examines the traditional use of elderberry fruit (Sambucus nigra), its chemical composition, indications based on traditional use, and safety profile in phytotherapy.
https://www.ema.europa.eu/en/medicines/herbal/sambuci-fructus
Source (scientific review – bioactive components, traditional use, and clinical evidence of Sambucus nigra): Porter RS, et al. A review of the antiviral properties of black elder (Sambucus nigra L.). Journal of International Medical Research. 2017. This review article examines the traditional use of elderberry (Sambucus nigra), its bioactive components (including flavonoids and anthocyanins), and available experimental and clinical evidence of its activity, with particular focus on respiratory viral infections.
https://pubmed.ncbi.nlm.nih.gov/28198157/
Zinc – an essential mineral for the normal function of the immune system
Zinc is an essential mineral that plays an important role in numerous physiological processes in the body, including the normal function of the immune system. According to the scientific assessment of the European Food Safety Authority (EFSA https://www.efsa.europa.eu/en), zinc contributes to the normal function of the immune system, which forms the basis for an approved health claim at the level of the European Union.
In accordance with the current regulation of the European Commission on permitted health claims for vitamins and minerals, it is stated that zinc contributes to the normal function of the immune system. This claim is based on the evaluation of scientific evidence and has been officially approved for use in communication about nutritional products.
Contemporary scientific reviews further examine the role of zinc in the normal functioning of the immune system, including its involvement in the activity of various immune response cells and in the regulation of numerous enzymatic processes. Based on the available scientific data, adequate zinc intake is considered an important part of a balanced diet, especially during periods of increased immune demand.
Due to its nutritional properties and the regulatorily confirmed role in the normal function of the immune system, zinc is often included in products intended for adults, either alone or in combination with vitamins and herbal extracts, as part of a comprehensive nutritional approach.
Source (regulatory health claim – zinc and the immune system): European Food Safety Authority (EFSA). Scientific Opinion on the substantiation of health claims related to zinc and normal function of the immune system. EFSA Journal. 2009;7(9):1229. This EFSA scientific opinion represents the scientific basis for the approved health claim that zinc contributes to the normal function of the immune system.
https://www.efsa.europa.eu/en/efsajournal/pub/1229
Source (regulatory document – EU health claims): Commission Regulation (EU) No 432/2012 of 16 May 2012. Establishing a list of permitted health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health. This regulatory document of the European Union lists approved health claims for vitamins and minerals, including the claim that zinc contributes to the normal function of the immune system.
https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32012R0432
Source (scientific review – the role of zinc in immunology): Gombart AF, Pierre A, Maggini S. A review of micronutrients and the immune system – working mechanisms and clinical relevance. Nutrients. 2020;12(1):236. This review article examines the role of zinc and other micronutrients in the normal function of the immune system and their clinical relevance.
https://pubmed.ncbi.nlm.nih.gov/31963293/
Ginger (Zingiber officinale) – herbal extract used in traditional phytotherapy
Ginger (Zingiber officinale) is a plant species whose rhizome has traditionally been used in phytotherapy.
In contemporary scientific literature, ginger has been the subject of numerous review articles analyzing its traditional use and bioactive components. According to published scientific reviews, ginger rhizome contains characteristic compounds such as gingerols and shogaols, which have been studied for their biological properties and potential significance in various physiological processes.
Review studies examine the antioxidant and anti-inflammatory properties of ginger, with particular attention to mechanisms associated with inflammatory processes in the body. Based on these scientific findings, ginger is often cited as a herbal ingredient with a long tradition of use during periods of general discomfort and increased physiological demand.
Source (scientific review – traditional use and bioactive components of ginger): Mashhadi NS, Ghiasvand R, Askari G, Hariri M, Darvishi L, Mofid MR. Anti-oxidative and anti-inflammatory effects of ginger in health and physical activity: review of current evidence. International Journal of Preventive Medicine. 2013;4(Suppl 1):S36–S42. This review summarizes evidence on the antioxidant and anti-inflammatory effects of ginger (Zingiber officinale), with a focus on bioactive components (e.g., gingerols and shogaols) and their potential clinical relevance.
https://pubmed.ncbi.nlm.nih.gov/23717767/
Source (scientific review – Zingiber officinale and anti-inflammatory activity): Grzanna R, Lindmark L, Frondoza CG. Ginger—an herbal medicinal product with broad anti-inflammatory actions. Journal of Medicinal Food. 2005;8(2):125–132. This review describes a wide range of anti-inflammatory mechanisms of ginger, including its effects on pathways related to prostaglandins and leukotrienes, and provides a professional framework for its use in conditions associated with inflammation.
https://pubmed.ncbi.nlm.nih.gov/16117603/
Source (scientific review – anti-inflammatory properties of ginger):
Grzanna R, Lindmark L, Frondoza CG. Ginger — an herbal medicinal product with broad anti-inflammatory actions. Journal of Medicinal Food. 2005 Summer; 8(2):125–132. This review article describes the pharmacological properties of ginger (Zingiber officinale), focusing on its anti-inflammatory mechanisms, including inhibition of prostaglandin and leukotriene synthesis and modulation of genes involved in the inflammatory response (e.g., cyclooxygenase and cytokines).
https://pmc.ncbi.nlm.nih.gov/articles/PMC12343617/#abstract1
Use in the early phase of cold and flu symptoms
Viranto Shot oral solution is a food for special medical purposes in a practical shot form, intended for the dietary management of adults with the common cold, flu, sore throat, cough, and respiratory complaints. Its use is recommended upon the appearance of the first symptoms of the common cold and flu. The early phase of symptoms represents the period when signs of infection are just beginning to develop and the body initiates its initial response to a viral infection.
Due to its practical shot form, Viranto Shot can be easily and quickly used without preparation, allowing action immediately after recognizing the first symptoms, both at home and outside the home.
Directions for use in adults
Viranto Shot is intended for adults. The recommended intake is two times per day, one bottle each time, in accordance with the instructions for use.
Thanks to its liquid shot form, the product can be easily consumed directly from the bottle. Before use, the contents should be shaken to ensure an even distribution of the ingredients.
Use after meals
Use after meals is recommended, as taking dietary supplements after food may contribute to better gastrointestinal tolerance and more comfortable consumption.
Professional sources indicate that taking dietary supplements with or after meals often helps reduce potential digestive discomfort and contributes to a better subjective experience during use, particularly in individuals with a sensitive digestive system.
Taking it after meals allows Viranto Shot to be easily incorporated into the daily routine, without the need for a special regimen or additional dietary adjustments, which facilitates regular and consistent use of the product.
Elderberry supplementation has been shown to significantly reduce symptoms of upper respiratory tract infections, such as the common cold and flu.
Source (meta-analysis of clinical studies – Sambucus nigra): Hawkins J, et al. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials. Complementary Therapies in Medicine. 2019;42:361–365.
https://pubmed.ncbi.nlm.nih.gov/30670267/
Source (regulatory review of traditional use – EMA HMPC): European Medicines Agency (EMA) – Committee on Herbal Medicinal Products (HMPC). Assessment report on Sambucus nigra L., fructus.
A regulatory and professional document that reviews the traditional use of elderberry fruit (Sambucus nigra), its composition, and available safety data, in line with the EU framework for traditional herbal medicinal products.
https://www.ema.europa.eu/en/medicines/herbal/sambuci-fructus
Source (scientific review – bioactive components and available evidence): Porter RS, et al. A review of the antiviral properties of black elder (Sambucus nigra L.). Journal of International Medical Research. 2017. A scientific review article that examines the traditional use of elderberry, its bioactive components (including flavonoids and anthocyanins), and experimental and clinical evidence of antiviral activity, with a focus on respiratory viral infections.
https://pubmed.ncbi.nlm.nih.gov/28198157/
Harnett J, Oakes K, Carè J, Leach M, Brown D, Cramer H, Pinder TA, Steel A, Anheyer D. The effects of Sambucus nigra berry on acute respiratory viral infections: A rapid review of clinical studies. Adv Integr Med. 2020 Dec;7(4):240-246. doi: 10.1016/j.aimed.2020.08.001. Epub 2020 Aug 22. PMID: 32864330; PMCID: PMC7443157. https://pubmed.ncbi.nlm.nih.gov/32864330/
Taken together, evidence from five clinical studies including 936 adults suggests that black elderberry (Sambucus nigra) fruit preparations, when taken within 48 hours of the onset of an acute respiratory viral infection, may reduce the duration and severity of common cold and flu symptoms in adults. The results indicate that they may reduce flu-like symptoms—including fever, headache, nasal congestion, and nasal discharge—if taken within the first 48 hours after symptom onset. Within 2–4 days of treatment, most participants experienced a significant reduction in symptoms, on average by about 50%.
Source (regulatory health claim – zinc and the immune system): European Food Safety Authority (EFSA). Scientific Opinion on the substantiation of health claims related to zinc and normal function of the immune system. EFSA Journal. 2009;7(9):1229. This EFSA scientific opinion provides the basis for the approved health claim that zinc contributes to the normal function of the immune system.
https://www.efsa.europa.eu/en/efsajournal/pub/1229
Source (regulatory document – permitted health claims in the EU): Commission Regulation (EU) No 432/2012 of 16 May 2012. Establishing a list of permitted health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health. This regulatory document of the European Union lists permitted health claims for vitamins and minerals, including the claim that zinc contributes to the normal function of the immune system, in accordance with Regulation (EC) No 1924/2006.
https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32012R0432
Source (scientific review – zinc and the immune system): Gombart AF, Pierre A, Maggini S. A review of micronutrients and the immune system – working mechanisms and clinical relevance. Nutrients. 2020;12(1):236. This review article examines the role of zinc and other micronutrients in the normal functioning of the immune system, with a focus on cellular and molecular mechanisms of the immune response.
https://pubmed.ncbi.nlm.nih.gov/31963293/
Copyright 2026 4uPharma. All Rights Reserved
Dajbog CMS, izrada sajta i SEO by Web Business Solutions
